Xinhua Silk Road: Why is Pien Tze Huang selected as one of China's brands favored by foreigners in 2024

Xinhua Silk Road: Why is Pien Tze Huang selected as one of China's brands favored by foreigners in 2024

BEIJING, Dec. 17, 2024 /PRNewswire/ -- Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang), a time-honored Chinese enterprise mainly engaging in pharmaceutical manufacturing, was selected as one of China's brands favored by foreigners...

Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer

Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer

CUPERTINO, Calif., Dec. 17, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in stage IIIb/IV non-small cell lung cancer (NSCLC). The...

KOSE Acquires Shares of Puri Co., Ltd. in Thailand and Makes It Subsidiary

KOSE Acquires Shares of Puri Co., Ltd. in Thailand and Makes It Subsidiary

- Increasing Presence in Global South Markets and Accelerating Global Strategy - TOKYO, Dec. 16, 2024 /PRNewswire/ -- KOSE Corporation, headquartered in Chuo Ward, Tokyo and Puri Co., Ltd., headquartered in Bangkok, Thailand, which operates the...

State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company helps the development of aquaculture industry

State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company helps the development of aquaculture industry

ATUSHI, China, Dec. 13, 2024 /PRNewswire/ -- On December 11, there was a busy scene in the factory base of Kizilsu Zhanyu Aquatic Products Co., Ltd., and the staff were busy releasing fish fry into the pond to prepare for the upcoming harvest...

MGSD Announces Results for 2024 Fiscal Year

MGSD Announces Results for 2024 Fiscal Year

NEW YORK, Dec. 13, 2024 /PRNewswire/ -- Maitong Sunshine Cultural Development Co., Ltd (OTCQB: MGSD), an enterprise that provides cultural tourism services and other related services and products, announced its financial results for the year ended...

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

YANTAI, China, Dec. 13, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK,...

Xinhua Silk Road: Pien Tze Huang boosts TCM globalization

Xinhua Silk Road: Pien Tze Huang boosts TCM globalization

BEIJING, Dec. 12, 2024 /PRNewswire/ -- Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd., a Fujian-based traditional Chinese medicine (TCM) company, has been striving to expand its overseas markets, enhancing the influence of TCM in regions such as...

Autoliv and JMC Form Strategic Partnership for Innovation and Expansion

Autoliv and JMC Form Strategic Partnership for Innovation and Expansion

STOCKHOLM, Dec. 12, 2024 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced that Jiangling Motors Co., Ltd (JMC), a renowned Chinese automotive manufacturer, and Autoliv...

"Disney Music Parade -Encore-" For Nintendo Switch™ Asia Release

"Disney Music Parade -Encore-" For Nintendo Switch™ Asia Release

TOKYO, Dec. 12, 2024 /PRNewswire/ -- Imagineer Co., Ltd., in collaboration with Walt Disney Japan Co., Ltd., announces the release of "Disney Music Parade -Encore-" for Nintendo Switch™ in Asia regions excluding Japan. Disney Music Parade -Encore-...

GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz™

GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz™

** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Multinational Phase 3 Clinical Trial protocols confirmed and initiated with leading global stroke...

  • 1
  • ...
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • ...
  • 24
  • menu
    menu